Wim van Harten
Technologies and services in oncology
In this group two research themes are covered.
Early Health Technology Assessment: Gradually we can expect Health Technology Assessment (HTA) not only to be involved in policy- and coverage decisions, but also in an earlier stage in the translational research process to anticipate on technological and environmental developments. We foresee to be increasingly involved in translational and clinical research projects.
Cancer Rehabilitation: Survivorship care and rehabilitation are important elements of a cancer center’s program.
More about this group
Our research
Our resources
Team members
Alumni
Highlights of this group
Policy proposals to increase the affordability of anticancer treatments
This project focuses on the affordability of medical treatments. High prices of anticancer drugs are a barrier to patients’ access to effective and appropriate treatments and are stressing healthcare systems. In this project, we are exploring the effects of innovative policies in the intellectual property, pricing, and R&D environment.
Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices
Article Nora Franzen in Jama Oncology.
Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices; A Systematic Review
News and stories from this group
Publications of this group
Contact our group